|By PR Newswire||
|February 9, 2014 01:56 PM EST||
CHENGDU, China, Feb. 9, 2014 /PRNewswire/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API), today announced that the earnings conference call for the second quarter of fiscal year 2014 ended December 31, 2013 to be held at 9:00 a.m. ET on Friday, February 14th, 2014.
Interested parties may access the call by dialing:
Conference ID: 4667572
It is advisable to dial in approximately 5 minutes prior to the start of the call.
Replay Dial-In Numbers:
From: 02/14/14 @ 12:00 pm Eastern Time
To: 02/28/14 @ 11:59 pm Eastern Time
Replay Pin Number: 4667572
This call is being web cast by ViaVid Broadcasting and can be accessed at ViaVid's website at the following link: http://public.viavid.com/index.php?id=107804
Headquartered at Chengdu, China, TPI is a pharmaceutical company that specializes in the development, manufacturing, marketing and sales of patented biopharmaceutical, mTCM, branded generics and API. TPI currently manufactures a comprehensive portfolio of 58 products, 24 of which are listed in the highly selective national medicine reimbursement list, 10 are included in the essential drug list (EDL) of China. For more information about TPI, please visit: http://www.tianyinpharma.com
Safe Harbor Statement
The Statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission.
Tel: +86-28-8551-6696 (Chengdu, China)
23rd Floor, Unionsun Yangkuo Plaza
No. 2, Block 3, South Renmin Road
SOURCE Tianyin Pharmaceutical Co., Inc.
The enterprise market will drive IoT device adoption over the next five years. In his session at @ThingsExpo, John Greenough, an analyst at BI Intelligence, division of Business Insider, analyzed how companies will adopt IoT products and the associated cost of adopting those products. John Greenough is the lead analyst covering the Internet of Things for BI Intelligence- Business Insider’s paid research service. Numerous IoT companies have cited his analysis of the IoT. Prior to joining BI In...
Jul. 6, 2015 09:00 PM EDT Reads: 895
Jul. 6, 2015 07:45 PM EDT Reads: 1,820
Jul. 6, 2015 07:45 PM EDT Reads: 1,551
Jul. 6, 2015 07:00 PM EDT Reads: 1,015
Jul. 6, 2015 06:15 PM EDT Reads: 1,928
Jul. 6, 2015 05:30 PM EDT Reads: 1,054
Jul. 6, 2015 05:00 PM EDT Reads: 1,917
Jul. 6, 2015 05:00 PM EDT Reads: 2,140
Jul. 6, 2015 04:30 PM EDT Reads: 588
Jul. 6, 2015 04:15 PM EDT Reads: 1,540
Jul. 6, 2015 03:45 PM EDT Reads: 1,744
Jul. 6, 2015 03:00 PM EDT Reads: 1,795
Jul. 6, 2015 03:00 PM EDT Reads: 1,787
Jul. 6, 2015 03:00 PM EDT Reads: 3,032
Jul. 6, 2015 03:00 PM EDT Reads: 846